Meanwhile, patients over 50 years old characterized by a ki67 ranging from 10% to 20% showed an IDEFS probability greater than patients with a ki67 percentage greater than 20% (Figure 3b), revealing a reduced tumor aggressiveness in older patients with a major cellular marker for proliferation expression. This evidence concerns the gene MKI67 and neoplasm.